 Connection
David Moreno to Waldenstrom Macroglobulinemia
This is a "connection" page, showing publications David Moreno has written about Waldenstrom Macroglobulinemia.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.714 |
|
|
|
-
Moreno DF, Fern?ndez de Larrea C. Clinical Implications of Genomic Profile in Waldenstr?m Macroglobulinemia. Hematol Oncol Clin North Am. 2023 08; 37(4):659-670.
Score: 0.876
-
Moreno DF, L?pez-Guerra M, Paz S, Oliver-Cald?s A, Mena MP, Correa JG, Battram AM, Osuna M, Rivas-Delgado A, Rodr?guez-Lobato LG, Card?s O, Tovar N, Cibeira MT, Jim?nez-Segura R, Blad? J, Rosi?ol L, Colomer D, Fern?ndez de Larrea C. Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenstr?m macroglobulinaemia. Br J Haematol. 2023 01; 200(2):187-196.
Score: 0.840
-
Moreno DF, de Larrea CF, Castillo JJ. New treatment strategies for Waldenstr?m macroglobulinemia. Clin Adv Hematol Oncol. 2022 Aug; 20(8):506-515.
Score: 0.829
-
Castillo JJ, Moreno DF, Arbelaez MI, Hunter ZR, Treon SP. CXCR4 mutations affect presentation and outcomes in patients with Waldenstr?m macroglobulinemia: A systematic review. Expert Rev Hematol. 2019 10; 12(10):873-881.
Score: 0.168
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|